Distinguished in Cervical Cancer

Dr. Enrique E. Hernandez

Gynecologic Oncology | Obstetrics and Gynecology
Temple Faculty Practice Plan Inc
3401 N Broad St, 
Philadelphia, PA 
Distinguished in Cervical Cancer
Temple Faculty Practice Plan Inc
3401 N Broad St, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Enrique Hernandez is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Philadelphia, Pennsylvania. Dr. Hernandez is rated as a Distinguished provider by MediFind in the treatment of Cervical Cancer. His top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Malignant Mixed Mullerian Tumor, Hysterectomy, and Endoscopy.

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 1 clinical trial in the study of Cervical Cancer.

Graduate Institution
University Of Puerto Rico School Of Medicine
Specialties
Gynecologic Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in PA
Hospital Affiliations
Temple University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

TEMPLE FACULTY PRACTICE PLAN INC
3401 N Broad St, Philadelphia, PA 19140

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Other, Drug, Biological
Study Drugs: Dactinomycin, Leucovorin Calcium, Methotrexate
Study Phase: Phase 3
A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary
A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary
Enrollment Status: Unknown
Publish Date: January 25, 2022
Intervention Type: Biological, Drug, Other
Study Drugs: Bleomycin Sulfate, Carboplatin, Cisplatin, Etoposide Phosphate, Paclitaxel
Study Phase: Phase 2
A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva (NCT #01595061)
A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva (NCT #01595061)
Enrollment Status: Unknown
Publish Date: December 29, 2021
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Cisplatin, Gemcitabine Hydrochloride
Study Phase: Phase 2
View 4 Less Clinical Trials

33 Total Publications

Uterine Fibroids and Their Association with Acute and Chronic Venous Thromboembolic Disease-An Expert Review of the Literature.
Uterine Fibroids and Their Association with Acute and Chronic Venous Thromboembolic Disease-An Expert Review of the Literature.
Journal: Journal of clinical medicine
Published: April 20, 2025
Similar Doctors
Distinguished in Cervical Cancer
Dr. David P. Warshal
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Cervical Cancer
Dr. David P. Warshal
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Redeemer Cancer Care Physicians Network, LLC

1648 Huntingdon Pike, 
Meadowbrook, PA 
 (7.1 miles away)
215-938-3555
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Warshal is a Gynecologic Oncologist and an Oncologist in Meadowbrook, Pennsylvania. Dr. Warshal is rated as a Distinguished provider by MediFind in the treatment of Cervical Cancer. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Lymphadenectomy. Dr. Warshal is currently accepting new patients.

Distinguished in Cervical Cancer
Dr. Lauren S. Krill
Obstetrics and Gynecology | Oncology | Gynecologic Oncology
Distinguished in Cervical Cancer
Dr. Lauren S. Krill
Obstetrics and Gynecology | Oncology | Gynecologic Oncology

Cooper Gyn Oncology Association PC

3 Cooper Plz, 301a, 
Camden, NJ 
 (4.8 miles away)
856-963-3963
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lauren Krill is an Obstetrics and Gynecologist and an Oncologist in Camden, New Jersey. Dr. Krill is rated as a Distinguished provider by MediFind in the treatment of Cervical Cancer. Her top areas of expertise are Cervical Cancer, Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Ovarian Carcinosarcoma, and Bladder Reconstruction. Dr. Krill is currently accepting new patients.

Distinguished in Cervical Cancer
Dr. Karim S. Elsahwi
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Cervical Cancer
Dr. Karim S. Elsahwi
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Hackensack Meridian Health Medical Group - Specialty Care PC

1945 Route 33, 
Neptune, NJ 
 (60.3 miles away)
Languages Spoken:
English
See accepted insurances

Karim Elsahwi is a Gynecologic Oncologist and an Oncologist in Neptune, New Jersey. Dr. Elsahwi is rated as a Distinguished provider by MediFind in the treatment of Cervical Cancer. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Hysterectomy, and Oophorectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hernandez's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile